A Clinical Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft in Patients With Thoracic Aortic Pathologies

  • participants needed
  • sponsor
    University of Arizona
Updated on 8 November 2020


A Phase II study to evaluate the safety and efficacy of the Relay Stent Graft in patients with descending thoracic aneurysms.


The purpose of this clinical trial is to assess and evaluate the safety and efficacy of the Relay Thoracic Stent-Graft in subjects with TAA compared to surgical repair subjects. This is a phase II multi-center, non-blinded, non-randomized study of treatment of the Relay Thoracic Stent-Graft in subjects with thoracic aortic aneurysms. The study will include 120 subjects treated with the Relay Thoracic Stent-Graft and 60 surgical controls enrolled at a maximum of 30 investigational sites. Pre-procedure baseline data will be gathered along with post-procedure assessments prior to hospital discharge and 1, 6, and 1-year post-implantation follow-ups in addition to an annual visit out to 5 years. Study Objectives There are two primary objectives: efficacy and safety. - Primary Efficacy will be evaluated by the device-related adverse event rate of endovascular repair (via Relay Thoracic Stent-Graft) through 1- year. - Primary Safety will be evaluated by comparing major adverse events through 1-year in subjects treated with the Relay Thoracic Stent-Graft to those who underwent open surgical repair. Secondary objectives include evaluation of the primary outcomes including endoleak (Type I, III and IV only), stent migration, lumen occlusion, deployment failure/conversion to surgery, and aneurysm rupture at time points other than 1-year; evaluation of individual outcomes of the composite safety endpoints (e.g., stroke, paraplegia, myocardial infarction, respiratory failure, renal failure, and aneurysm-related mortality) at time points other than 1-year; comparison of the clinical utilities (duration of procedure, procedural blood loss, length of ICU and hospital stay, time in ICU) of the endovascular and surgical repair groups; device integrity failures, vascular access difficulties and analysis of the change in lesion size at 6-months, 1 year, and 2 -5 years post-procedure as compared to 1-month. It is planned to enroll 120 subjects with diagnosed TAA into the endovascular cohort. Sixty (60) surgical controls will also be included. For purposes of this study protocol, surgical controls, or surgical subjects, are those treated by open surgical repair. The study will be conducted at a maximum of 30 investigational sites in order to enroll the patient population needed for analysis. Subjects will be enrolled on a first come / first serve basis; however, a single investigational site may not enroll more than 30% of the enrollment total.

Condition Aortic Aneurysm, Thoracic
Treatment Relay Thoracic Stent-Graft, Surgical repair of the thoracic aneurysm
Clinical Study IdentifierNCT00998491
SponsorUniversity of Arizona
Last Modified on8 November 2020


How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note